The U.S. Centers for Disease Control and Prevention (CDC) today announced its current director endorsed the Advisory Committee on Immunization Practices’ (ACIP) recommendations for the use of new Respiratory Syncytial Virus (RSV) vaccines for people ages 60 years and older.
On June 29, 2023, Director Rochelle P. Walensky, M.D., M.P.H., confirmed RSV vaccines would become available for the 2023 RSV season using shared clinical decision-making.
Read More
